ERBB2 and breast cancer: Hence, in high-risk HER2+ BC populations, doublet platinum taxane-based chemotherapy regimens, such as carboplatin with docetaxel, have been demonstrated to be a comparable alternative in select patients who should be spared from receiving anthracycline.